Application of boron neutron capture therapy to the treatment of anaplastic thyroid carcinoma: Current status and future perspectives

Current Opinion in Endocrinology and Diabetes

Volumn 12, Issue 5, 2005, Pages 352-355

  Pisarev, Mario A ^a,b   Dagrosa, Maria A ^c   Juvenal, Guillermo J ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c CNEA ^*

Author keywords

Anaplastic thyroid carcinoma; Boron neutron capture therapy

Indexed keywords

BORON 10;

ANAPLASTIC CARCINOMA; CARCINOMA CELL; CELL DEATH; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; MELANOMA; NEUTRON CAPTURE THERAPY; NONHUMAN; NUDE MOUSE; REVIEW; THYROID CARCINOMA; TUMOR GROWTH;

EID: 26444603374     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.med.0000178269.16988.b1     Document Type: Review

References (30)

1. Barth R, Coderre J, Vicente G, Blue T. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 2005; 11:3987-4002. This review provides a basis for BNCT and a critical analysis of the results concerning melanomas and glioblastomas.
2. Nakagawa Y, Pooh K, Kobayashi T, et al. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J Neurooncol 2003; 62:87-99.
3. Diaz AZ. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinicians point of view. J Neurooncol 2003; 62:101-109.
4. Busse PM, Harling OH, Palmer MR, et al. A critical examination of the results of the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 2003; 62:111-121.
5. Capala J, Stenstam BH, Sköld S, et al. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol 2003; 62:135-144.
6. Fukuda H, Hiratsuka J, Honda C, et al. Boron neutron capture therapy of malignant melanoma using B-10-paraborophenylalanine wit special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res 1994; 138:435-442.
7. Gonzalez SJ, Bonomi MR, Santa Cruz GA, et al. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl Radiat Isot 2004; 61:1101-1105.
8. Ain KB. Anaplastic thyroid carcinoma: behavior, biology and therapeutic approaches. Thyroid 1998; 8:715-726.
9. Pacini F, De Groot LJ. Thyroid neoplasia. Chapter 18 on http://www.thyroid manager.org. Accessed 12 August 2005.
10. Haugen BR. Redifferentiation therapy in advanced thyroid cancer. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4:175-180. This is an updated review of the different strategies available for treating thyroid cancer.
11. Haugen BR, Larson LL, Pugazhenthi U, et al. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer thyroid carcinoma cell lines and predict responses to treatment with retinoids. J Clin Endocrinol Metab 2004; 89:272-280.
12. Schmutzler C, Koehrle J. Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 2000; 10:393-406.
13. De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000; 80:1083-1105.
14. 131| therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/l-symporter gene. Endocrinology 1997; 138:4493-4496.
15. Undifferentiated thyroid carcinoma. http://www.clinicaltrials.com.: Accessed 8 July 2005.
16. Dagrosa MA, Viaggi ME, Kreiman E, et al. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy. Thyroid 2002; 12:7-12.
17. 18F-DOPA analogue. J Neurooncol 1997; 33:163-169.
18. Wittig A, Sauerwein WA, Coderre JA. Mechanisms of transport of p-boronophenylalanine through the cell membrane in vitro. Radiat Res 2000; 153: 173-180.
19. Slatkin DN, Nawrocky MM, Coderre JA, et al. Boron concentration in rat tissues after partial hepatectomy and a single injection of L-BPA/fructose complex. In: Larsson B, Crawford J, Weinreich R, editors. Advances in neutron capture therapy. Amsterdam: Elsevier; 1997, pp. 229-223.
20. Viaggi M, Dagrosa MA, Belli C, et al. A new animal model for human undifferentiated thyroid carcinoma. Thyroid 2003; 13:529-536.
21. Fairchild RG, Kahl SB, Lester BH, et al. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res 1990; 50:4860-4865.
22. Hill J, Kahl SB, Kaye A, et al. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci USA 1992; 89: 1785-1789.
23. Callahan DE, Forte T, Afzal J, et al. Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Int J Radiat Oncol Biol Phys 1999; 45:761-771.
24. Dagrosa MA, Viaggi M, Jimenez Rebagliati R, et al. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. Mol Pharm 2005; 2:151-156.
25. Dagrosa MA, Viaggi M, Jimenez Rebagliati R, et al. Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC). Appl Radiat Isot 2004; 61:911-915.
26. Dagrosa MA, Viaggi M, Longhino J, et al. Experimental application of boron neutron capture therapy (BNCT) to undifferentiated thyroid carcinoma (UTC). Int J Radiat Oncol Biol Phys 2003; 57:1084-1092.
27. Rydberg B. Clusters of DNA damage induced by ionizing radiation: formation of short DNA fragments: II. Experimental detection. Radiat Res 1996; 145: 200-209.
28. Viaggi M, Dagrosa MA, Longhino J, et al. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP. Appl Radiat Isot 2004; 61:905-909.
29. Agote M, Viaggi M, Kreimann E, et al. Influence of nicotinamide on the radiosensitivity of normal and goitrous thyroid in the rat. Thyroid 2001; 11: 1003-1007.
30. Kiger JL, Kiger WS, Patel H, et al. Effects of boron neutron capture irradiation on the normal lung of rats. Appl Radiat Isot 2004; 61:969-973.